newsfilter
← Latest News
GlobeNewswire·

CalciMedica Announces One-for-Five Reverse Stock Split

CALC
  • CalciMedica Inc. (NASDAQ: CALC) announced a 1-for-5 reverse stock split effective at 5:00 p.m. ET on August 28, 2026.
  • The split was approved by stockholders on August 19, 2026, to comply with Nasdaq Capital Market minimum bid price requirements.
  • Shares will begin trading on a split-adjusted basis on August 31, 2026, under symbol "CALC" with new CUSIP 38942Q301.
  • The transaction will reduce outstanding shares from approximately 34.5 million to 6.9 million, while authorized shares decrease from 500 million to 100 million.
  • Fractional shares will not be issued; holders entitled to fractional shares will receive cash payments instead.
  • Stock options, restricted stock units, & warrants will be adjusted proportionally, causing a corresponding increase in their exercise prices.
  • Investors holding shares through brokers or nominees will have positions automatically adjusted without requiring further action.
  • CalciMedica is a clinical-stage biopharmaceutical company developing CRAC channel inhibition therapies, including Auxora™ & CM5480.